A drug with the SMILES Cc1nn(Cc2c(F)c(F)c(F)c(F)c2F)c(C)c1NC(=O)c1nn(C)c(C)c1Br has a hERG inhibition at a concentration of 1uM of -6.028\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1nn(Cc2c(F)c(F)c(F)c(F)c2F)c(C)c1NC(=O)c1nn(C)c(C)c1Br
Cc1nn(Cc2c(F)c(F)c(F)c(F)c2F)c(C)c1NC(=O)c1nn(C)c(C)c1Br
4-bromo-N-[3,5-dimethyl-1-[(2,3,4,5,6-pentafluorophenyl)methyl]pyrazol-4-yl]-1,5-dimethylpyrazole-3-carboxamide